John E. Kasik
Impact in
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology
-
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Papers in
- Pharmacology 10
- Antibiotics Pharmacokinetics and Efficacy 6
-
- Bioactive Compounds and Antitumor Agents 2
- Co-authors
- William R. Barclay (8 shared papers)Benjamin Burrows (4 shared papers)Albert H. Niden (5 shared papers)Michael R. Alexander (7 shared papers)Bernard W. Janicki (1 shared paper)Edgar E. Ribi (1 shared paper)Robert C. Good (1 shared paper)William M. Busey (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (6 papers)CHEST Journal (4 papers)The Lancet (1 paper)Tuberculosis (1 paper)JAMA (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
John E. Kasik
38 papers receiving 743 citations
Peers
Comparison fields: 5 of 76
- Infectious Diseases 206
- Pulmonary and Respiratory Medicine 305
- Molecular Medicine 44
- Pharmacology 98
- Toxicology 30
Countries citing papers authored by John E. Kasik
This map shows the geographic impact of John E. Kasik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Kasik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Kasik more than expected).
Fields of papers citing papers by John E. Kasik
This network shows the impact of papers produced by John E. Kasik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Kasik. The network helps show where John E. Kasik may publish in the future.
Co-authors
The 25 scholars most cited alongside John E. Kasik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1961 | 244 | |
| 2 | 1973 | 120 | |
| 3 | 1965 | 52 | |
| 4 | 1981 | 47 | |
| 5 | 1979 | 37 | |
| 6 | 1965 | 35 | |
| 7 | 1965 | 35 | |
| 8 | 1972 | 32 | |
| 9 | 1973 | 31 | |
| 10 | 1968 | 30 | |
| 11 | 1989 | 28 | |
| 12 | 1979 | 26 | |
| 13 | 1973 | 21 | |
| 14 | 1982 | 20 | |
| 15 | 1966 | 17 | |
| 16 | 1967 | 12 | |
| 17 | 1981 | 12 | |
| 18 | 1981 | 12 | |
| 19 | 1982 | 11 | |
| 20 | 1976 | 10 |
About John E. Kasik
John E. Kasik is a scholar working on Pharmacology, Toxicology, Infectious Diseases, Pulmonary and Respiratory Medicine and Molecular Medicine, having authored 40 papers that have together received 918 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (10 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers), Mycobacterium research and diagnosis (5 papers), Antibiotic Resistance in Bacteria (4 papers), Infectious Diseases and Tuberculosis (3 papers), Immunotoxicology and immune responses (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). The work is most often cited by research in Infectious Diseases (206 citations), Pulmonary and Respiratory Medicine (305 citations), Molecular Medicine (44 citations), Pharmacology (98 citations) and Toxicology (30 citations). John E. Kasik has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include William R. Barclay, Benjamin Burrows, Albert H. Niden, Michael R. Alexander, Bernard W. Janicki, Edgar E. Ribi, Robert C. Good, William M. Busey, Charles E. Ulrich and EMANUEL WOLINSKY. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, CHEST Journal, The Lancet, Tuberculosis and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.